Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $90
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $99 to $90.
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $99 to $90.